Week of January 3, 2022 MMWR Weekly Briefing

This episode discusses four MMWR reports. The first report looks at the effectiveness of the Pfizer-BioNTech vaccine against multisystem inflammatory syndrome in children ages 12-17 years. The next report looks at the risk for newly diagnosed diabetes after COVID-19 infection among children. The third report examines COVID-19 vaccination during pregnancy and its association with preterm or small-for-gestational-age at birth. And the last report describes severe COVID-19 outcomes among people ages 18 years and older who have completed their primary vaccination series.